WASHINGTON D.C. (WSET) — Financial relief is on the way for millions of Americans with diabetes.
Drugmaker Eli Lilly has chosen to cut some insulin prices, capping out-of-pocket costs at $35.
President Joe Biden has praised the move, using it to highlight the Inflation Reduction Act capping insulin prices for seniors on Medicare last year.
SEE ALSO: Endangered missing woman was last seen with an 'unknown man' in Lynchburg: Police
Biden says Eli Lilly's decision could be a game-changer for everyone.
"35 bucks. Guess what that means? Every other company making insulin is going to have to lower their prices to 35 because they can't compete," Biden said.
According to Eli Lilly, out of the nearly eight-point-5 million Americans who use insulin, nearly three million rely on their products.
The following data provided by the White House breaks down how many adults living in each state could experience lower insulin costs as a result of this decision and the Inflation Reduction Act.
Percentage of Adults Aged 18 Years or Older with Diagnosed Diabetes, by Racial or Ethnic Group, United States, 2018-2019
Estimated Number of Adults 18 and Older with Diagnosed Diabetes by State
Here are the numbers for Virginia and the states surrounding the Commonwealth. According to the White House, these estimates are developed from a base that "incorporates the 2020 Census, Vintage 2020 estimates, and (for the U.S. only) 2020 Demographic Analysis estimates."
Virginia
Maryland
North Carolina
Tennessee
West Virginia
Ohio
SEE ALSO: Nelson County man accused of sending nude images to child: Sheriff
Additional information on how many seniors in each state are already benefiting is available here from the Department of Health and Human Services.